Full text loading...
-
Treating Age-Related Macular Degeneration - Interaction of VEGF-Antagonists with their Target
- Source: Mini Reviews in Medicinal Chemistry, Volume 9, Issue 9, Aug 2009, p. 1127 - 1135
-
- 01 Aug 2009
Abstract
The neutralization of VEGF is the current treatment of choice for age-related macular degeneration. Current approaches include anti-VEGF-antibodies and -Fab Fragments, aptamers, soluble receptors (Traps) and siRNA. The molecular properties of VEGF and its antagonists are reviewed and the pathways of action of these substances are discussed.
© Bentham Science Publishers